TrialClinical and experimental nephrology2015

Anti-albuminuric effects of spironolactone in patients with type 2 diabetic nephropathy: a multicenter, randomized clinical trial.

Sawako Kato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.